Implementations by Phenotype

Title Phenotype Institution Algorithm Type Total Cases Total Controls PPVsort descending Sensitivity
NU eMERGEseq CRC cases and controls Colorectal Cancer (CRC) Northwestern University Case, Control
CCHMC T1D Implementation Type 1 Diabetes Case Only
Mayo SLE Implementation SLE (Systemic Lupus Erythematosus) using SLICC (Systemic Lupus Internation Collaborating Clinics) Criteria Mayo Clinic Case, Control 0 0
Marshfield DILI algorithm implementation Drug Induced Liver Injury Marshfield Clinic Research Foundation Case, Control 10%
Mayo Clinic DILI implementation Drug Induced Liver Injury Mayo Clinic Case, Control 16%, 100%
Mount Sinai Biobank DILI algorithm Implementation Drug Induced Liver Injury Mount Sinai School of Medicine Case, Control 29%, 100%
Columbia Clinical Data Warehouse DILI algorithm Implementation Drug Induced Liver Injury Columbia University Case, Control 32%, 100%
CHOP implementation Case 2 Appendicitis CHOP Case Only 2 50%
CHOP implementation Case 3 Appendicitis Case Only 10 50%
DR Vanderbilt Implementation Diabetic Retinopathy Vanderbilt University Case, Control 68%, 100%
Dementia GHC Implementation Dementia Group Health Cooperative Case Only 73% 55%
Lipids Marshfield Implementation Lipids Marshfield Clinic Research Foundation Case Only 79% 95%
DR Marshfield Implementation Diabetic Retinopathy Marshfield Clinic Research Foundation Case, Control 80%, 98% 98%, 86%
Geisinger CRS CRS (Chronic Rhinosinusitis) Geisinger Case, Control 81%, 95%
HDL Marshfield Implementation High-Density Lipoproteins (HDL) Marshfield Clinic Research Foundation Case Only 82% 92%
Hypothyroidism Mayo Implementation Hypothyroidism Mayo Clinic Case, Control 82%, 96% 99%
Dementia Vanderbilt Implementation Dementia Vanderbilt University Case Only 84%
Autism Validation Autism CHOP Case Only 50 85% 74%
CHOP Part II- NONRESPONDERS Epilepsy/Antiepileptic drug response algorithm CHOP Case Only 85%
WBC Northwestern Implementation White Blood Cell Indices Northwestern University Case Only 85% 100%
CHOP Part II- RESPONDERS Epilepsy/Antiepileptic drug response algorithm Case Only 85%
CHOP implementation Case 1 and Controls Appendicitis CHOP Case, Control 86%, 100%
Northwestern University Validation Colorectal Cancer (CRC) Northwestern University Case, Control 50 50 86%, 98% 92%
CCHMC - PART 1 Epilepsy/Antiepileptic drug response algorithm Cincinnati Children's Hospital Medical Center Case Only 129 86%
Columbia - AID Phenotype Autoimmune Disease Phenotype Columbia University Case, Control 132 29 86%, 93%

Pages